4Miravitlles M, Soriano JB, Garcia-Rio F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities [J]. Thorax, 2009, 64(10): 863-868.
5Calverley PM. COPD: early detection and intervention[J]. Chest, 2000, 117(5 Suppl 2): 365S-371S.
4Rabe K F,Hurd S,Anzueto A,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary[J].Am J Respir Crit Care Med,2007,176(6):532.
5Buist A S,McBurnie M A,Vollmer WMm,et al.International variation in the prevalence of chronic obstructive pulmonary disease (The BOLD Study):a population-based prevalence study[J].Lancet,2007,370(9589):741.
6Menezes A M B,Perez-Padilla R,Jardim J R B,et al.Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study):a prevalence study[J].Lancet,2005,366 (9500):1875.
7Halbert R J,Natoli J L,Gano A,et al.Global burden of COPD:systematic review and meta analysis[J].Eur Respir J,2006,28(3):523.
8Regional COPD working group.COPD prevalence in 12 Asia-Pacific countries and regions:projections based on the COPD prevalence estimation model[J].Respirology,2003,8(2):192.
9Zhong N,Wang C,Yao W,et al.Prevalence of chronic obstructive pulmonary disease in China:a large,population-based survey[J].Am J Respir Crit Care Med,2007,176(8):732.
10Reilly K H,Gu D,Duan X,et al.Risk Factors for Chronic Obstructive Pulmonary Disease Mortality in Chinese Adults[J].Am J Epidemiol,2008,167(8):998.
3Bellamy D, Smith J. Role of primary care in early diagnosis and effective management of COPD[J]. Int. Clln Pract, 2007,61 (8) : 1380-1389.
4Joo MJ, Lee TA, Weiss KB. Geographic variation of spirometry use in newly diagnosed COPD[J]. Chest, 2008, 134(1) :38-45.
5Damarla M, Celli BR, Mullerova HX, et al. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure[J]. Respir Care, 2006,51(10) : 1120 -1124.
6Thorn J, Tilling B, Lisspers K, et al. Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis [J]. Prim Care Respir J,2012,21(2) :159- 166.
7Milic-Emili J. Inspiratory capacity and exercise tolerance in chronic obstructive pulmonary disease[J]. Can Respir J, 2000,7(3) :282-285.
8Zaman M, Mahmood S, Altayeh A. Low inspiratory capacity to total hmg capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbation[J]. Am J Med Sci,2010,339(5) :411-414.
9Bhatt SP, Kim YI, Wells JM, et al. FEV(1)/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices[J]. Ann Am Thorac Soc, 2014,11(3) :335-341.
10Perez-Padilla R, Wehrmeister FC, Celli BR, et al. Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study [ J ]. PLoS One, 2013,8(8) : e67960.
